1. Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects.
- Author
-
Jeyaseelan S, Kannan MS, Briggs RE, Thumbikat P, and Maheswaran SK
- Subjects
- Androstadienes pharmacology, Animals, Bacterial Toxins genetics, Benzoquinones, CD18 Antigens metabolism, Calcium metabolism, Cattle, Enzyme Activation, Exotoxins genetics, Hemolysin Proteins genetics, Lactams, Macrocyclic, Leukocytes cytology, Leukocytes metabolism, Macrophages, Alveolar drug effects, Macrophages, Alveolar metabolism, Protein-Tyrosine Kinases antagonists & inhibitors, Protein-Tyrosine Kinases physiology, Quinones pharmacology, Rifabutin analogs & derivatives, Wortmannin, Bacterial Proteins, Bacterial Toxins metabolism, Exotoxins metabolism, Hemolysin Proteins metabolism, Lymphocyte Function-Associated Antigen-1 metabolism, Mannheimia haemolytica metabolism, Protein-Tyrosine Kinases metabolism, Signal Transduction
- Abstract
The leukotoxin (LktA) produced by Mannheimia haemolytica binds to bovine lymphocyte function-associated antigen 1 (LFA-1) and induces biological effects in bovine leukocytes in a cellular and species-specific fashion. We have previously shown that LktA also binds to porcine LFA-1 without eliciting any effects. These findings suggest that the specificity of LktA effects must entail both binding to LFA-1 and activation of signaling pathways which are present in bovine leukocytes. However, the signaling pathways leading to biological effects upon LktA binding to LFA-1 have not been characterized. In this context, several reports have indicated that ligand binding to LFA-1 results in activation of a nonreceptor tyrosine kinase (NRTK) signaling cascade. We designed experiments with the following objectives: (i) to determine whether LktA binding to LFA-1 leads to activation of NRTKs, (ii) to examine whether LktA-induced NRTK activation is target cell specific, and (iii) to determine whether LktA-induced NRTK activation is required for biological effects. We used a biologically inactive mutant leukotoxin (DeltaLktA) for comparison with LktA. Our results indicate that LktA induces tyrosine phosphorylation (TP) of the CD18 tail of LFA-1 in bovine leukocytes. The DeltaLktA mutant does not induce TP of the CD18 tail, albeit binding to bovine LFA-1. LktA-induced TP of the CD18 tail was attenuated by an NRTK inhibitor, herbimycin A; a phosphatidylinositol 3'-kinase (PI 3-kinase) inhibitor, wortmannin; and a Src kinase inhibitor, PP2, in a concentration-dependent manner. Furthermore, LktA induces TP of the CD18 tail in bovine, but not porcine, leukocytes. Moreover, LktA-induced intracellular calcium ([Ca2+]i) elevation was also inhibited by herbimycin A, wortmannin, and PP2. Thus, our data represent the first evidence that binding of LktA to bovine LFA-1 induces a species-specific NRTK signaling cascade involving PI 3-kinase and Src kinases and that this signaling cascade is required for LktA-induced biological effects.
- Published
- 2001
- Full Text
- View/download PDF